跳至主要内容
临床试验/NCT01558336
NCT01558336已完成3 期

Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel

University of Khartoum1 个研究点 分布在 1 个国家目标入组 520 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
520
试验地点
1
主要终点
cure rate

研究概览

简要总结

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

详细描述

A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • School children

排除标准

  • Taking praziquantel

研究组 & 干预措施

Praziguantel

Experimental

tablet single dose

干预措施: praziquantel (Drug)

结局指标

主要结局

cure rate

时间窗: one year

The reduction of the prevalence and intensity of S.haematobium infection following a single dose of praziquantel40mg/kg

次要结局

  • reduction in the intensity of infection by(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ishag Adam

Professor

University of Khartoum

研究点 (1)

Loading locations...

相似试验